Physician profile
Tamara Rae Brunk
NPI 1336477728
$1,772.64
in general payments reported to CMS, 2019-2025
24 companies · $736 in 2025
The $736 reported for 2025 was more than what 87% of Critical Care Medicine (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $203).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $228 · 2023: $326 · 2024: $482 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,544.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $421.26 | 2022-2025 | Verquvo, Belsomra, Steglatro |
| Boston Scientific Corporation | $238.75 | 2022-2025 | Watchman Access System |
| Endologix LLC | $173.06 | 2025 | Torus Stent Graft System, Endocross Device |
| Regeneron Healthcare Solutions, INC. | $119.41 | 2024-2025 | Dupixent |
| Corcept Therapeutics | $108.34 | 2025 | Korlym |
| Novo Nordisk INC | $82.04 | 2024-2025 | Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $74.41 | 2022-2023 | Xarelto |
| Nevro Corp. | $72.09 | 2024 | Senza |
| Novartis Pharmaceuticals Corporation | $64.84 | 2024 | |
| Amgen INC. | $55.60 | 2024-2025 | Repatha, Otezla, Repatha |
| Insulet Corporation | $47.09 | 2024 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $45.62 | 2024-2025 | |
| Baxter Healthcare | $41.50 | 2025 | Hillrom - Monarch Airway Clearance System |
| Paratek Pharmaceuticals, INC. | $40.53 | 2025 | Nuzyra, Xhance |
| Impulse Dynamics (USA) INC. | $33.36 | 2023 | Optimizer |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $25.92 | 2025 | Nimbl, Flexitouch Plus |
| Abbott Laboratories | $20.39 | 2023 | Mitraclip |
| Inspire Medical Systems, INC. | $18.36 | 2025 | Inspire |
| Lilly USA, LLC | $17.33 | 2022 | |
| Scpharmaceuticals INC. | $16.78 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $15.83 | 2023 | |
| Ethicon US, LLC | $13.82 | 2022 | |
| Pfizer INC. | $13.50 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $12.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Brunk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.